Corcept Therapeutics, Inc. (CORT)

34.86 +0.62 (+1.81%) USD  |  NASDAQ  |  Feb 20, 15:17
More

Corcept Therapeutics Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Axsome Therapeutics, Inc. Upgrade
United Therapeutics Corp. Upgrade
Harrow, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Amneal Pharmaceuticals, Inc. Upgrade